Rainbow Children’s Medicare 26th AGM to Approve Rs 3 per Equity Share

Rainbow Children's Medicare to seek shareholder approval for Rs 3 per share final dividend at its 26th Annual General Meeting.  

by Damodharan N

Updated Jul 10, 2024

Article continues below advertisement
Rainbow Children’s Medicare 26th AGM to Approve Rs 3 per Equity Share

Rainbow Children’s Medicare Limited AGM's agenda includes crucial items such as the adoption of the company’s audited standalone and consolidated financial statements for the fiscal year ending March 31, 2024. Shareholders will also deliberate on the proposed dividend payout of Rs 3 per Equity Share for the same financial year.

  • Proposed Final Dividend: Rs 3 per share
  • Amount Proposed: Rs 304.51 million

The Board of Directors recommended these dividends, which are subject to shareholder approval at the upcoming 26th Annual General Meeting (AGM) scheduled for July 30, 2024. at 11:30 A.M. IST via Video Conferencing/Other Audio-Visual Means.

Rainbow Children’s Medicare Annual Report

Rainbow Children’s Medicare Limited operates on a hub-and-spoke model, where central hospitals provide comprehensive outpatient and inpatient care with an emphasis on tertiary and quaternary services. Satellite facilities focus on emergency care in pediatrics and obstetrics, extensive outpatient services, and NICU services.

The company has successfully implemented this model in Hyderabad and Bengaluru and plans to expand into Chennai, the National Capital Region, and tier-2 cities in Southern India​.

Business Verticals and Activities: 

The company's activities encompass pediatric care, obstetrics, and neonatal services, with a robust operational model that includes central hospitals and satellite facilities to ensure widespread healthcare accessibility. Key services include emergency care, outpatient services, and comprehensive pediatric and NICU services​.

Financial Performance for FY 2023-24: 

Rainbow Children’s Medicare Limited achieved its highest-ever revenue of ₹12,969.00 million. The EBITDA for FY 2023-24 was ₹4,288.85 million, reflecting an 8.20% increase from the previous year.

The Profit After Tax (PAT) was ₹2,182.87 million, a 2.78% increase compared to FY 2022-23. Other income saw a 20.08% surge, primarily due to increased income from mutual funds and the reversal of expected credit losses.

In FY 2024, Rainbow Children’s Medicare Limited achieved an EBITDA margin of 33.1%. The Return on Capital Employed (ROCE) for the same period was 21.0%. The Return on Equity (ROE) for FY 2024 was 18.7%, showing a decline from 25.4% in FY 2023 and 26.4% in FY 2022.

Additionally, the dividend per share for FY 2024 remained consistent at ₹3, the same as in FY 2023, but higher than the ₹2 per share dividend in FY 2022.Total expenses rose by 12.63%, driven by higher employee benefits, professional fees to doctors, and other operational expenses​.

Standalone Financials:

  • Total Income: ₹12,735.10 million
  • Total Expenses: ₹9,842.93 million
  • Profit Before Tax: ₹2,892.17 million
  • Profit After Tax: ₹2,148.91 million

Consolidated Financials:

  • Total Income: ₹13,339.64 million
  • Total Expenses: ₹10,391.51 million
  • Profit Before Tax: ₹2,948.13 million
  • Profit After Tax: ₹2,182.87 million​.

New additions: 

The company commissioned three new spoke hospitals and added two new blocks in existing hospitals, resulting in the addition of 280 beds, the highest ever in a single year. Significant market penetration was achieved with new facilities in Hyderabad, Bengaluru, and Chennai​.

Management’s Discussion and Analysis: 

The company's clinical and operational excellence, combined with cost optimization measures, enabled it to achieve significant financial milestones. Two hospitals received Joint Commission International (JCI) accreditation, enhancing the company's reputation for high-quality healthcare. 

Future Outlook: 

Rainbow Children’s Medicare Limited plans to expand its hub-and-spoke model to new regions, including Chennai and the National Capital Region, and into tier-2 cities in Southern India.

The company aims to enhance its market penetration and continue adding hospital beds, with significant capital expenditures planned for the coming years. The strategic focus includes potential mergers and acquisitions to drive inorganic growth and maintain robust financial health​ .

Rainbow Children’s Medicare Limited demonstrated resilience and strong financial performance in FY 2023-24, achieving its highest-ever revenue, EBITDA, and PAT. With strategic expansions and a commitment to clinical excellence.

Read the full Annual Report and Notice Here 

Article continues below advertisement
Article continues below advertisement

Rainbow Children’s Medicare Limited 

 Rainbow Children's Medicare Ltd, founded in 1999 by Dr. Ramesh Kancharla, is India's leading chain of hospitals specializing in pediatric, obstetrics, and gynecology care.

Starting with a single hospital in Hyderabad, the company has expanded to 19 hospitals and 4 clinics across 6 cities, including Bengaluru, Chennai, and Delhi. Rainbow's integrated model provides comprehensive pediatric and perinatal services, including the renowned Rainbow Children's Heart Institute.

Rainbow Children’s Medicare 26th AGM to Approve Rs 3 per Equity Share - FAQs

1. What was the revenue for Rainbow Children’s Medicare in FY 2023-24?        

The revenue for Rainbow Children’s Medicare in FY 2023-24 was ₹12,969.00 million.

2. What was the EBITDA for FY 2023-24?  

The EBITDA for FY 2023-24 was ₹4,288.85 million.

3. How much did the EBITDA increase from the previous year?  

The EBITDA increased by 8.20% from the previous year.

4. What was the Profit After Tax (PAT) for FY 2023-24?  

The Profit After Tax (PAT) for FY 2023-24 was ₹2,182.87 million.

5. What was the PAT increase percentage compared to FY 2022-23?  

The PAT increased by 2.78% compared to FY 2022-23.

6. What was the EBITDA margin for FY 2024?  

The EBITDA margin for FY 2024 was 33.1%.

7. What was the Return on Capital Employed (ROCE) for FY 2024?  

The Return on Capital Employed (ROCE) for FY 2024 was 21.0%.

8. What was the Return on Equity (ROE) for FY 2024?  

The Return on Equity (ROE) for FY 2024 was 18.7%.

9. What was the ROE for FY 2023?  

The Return on Equity (ROE) for FY 2023 was 25.4%.

10. What was the ROE for FY 2022?  

The Return on Equity (ROE) for FY 2022 was 26.4%.

11. What was the dividend per share for FY 2024?  

The dividend per share for FY 2024 was ₹3.

12. What was the dividend per share for FY 2023?      

The dividend per share for FY 2023 was ₹3.

13. What was the dividend per share for FY 2022?  

The dividend per share for FY 2022 was ₹2.

14. What was the total income for standalone financials in FY 2023-24?  

The total income for standalone financials in FY 2023-24 was ₹12,735.10 million.

15. What were the total expenses for standalone financials in FY 2023-24?  

The total expenses for standalone financials in FY 2023-24 were ₹9,842.93 million.

16. What was the profit before tax for standalone financials in FY 2023-24?  

The profit before tax for standalone financials in FY 2023-24 was ₹2,892.17 million.

17. What was the profit after tax for standalone financials in FY 2023-24?  

The profit after tax for standalone financials in FY 2023-24 was ₹2,148.91 million.

18. What was the total income for consolidated financials in FY 2023-24?  

The total income for consolidated financials in FY 2023-24 was ₹13,339.64 million.

19. What were the total expenses for consolidated financials in FY 2023-24?      

The total expenses for consolidated financials in FY 2023-24 were ₹10,391.51 million.

20. What was the profit before tax for consolidated financials in FY 2023-24?  

The profit before tax for consolidated financials in FY 2023-24 was ₹2,948.13 million.

21. What was the profit after tax for consolidated financials in FY 2023-24?  

The profit after tax for consolidated financials in FY 2023-24 was ₹2,182.87 million.

22. How many new spoke hospitals were commissioned in FY 2023-24?  

Three new spoke hospitals were commissioned in FY 2023-24.

23. How many new blocks were added in existing hospitals in FY 2023-24?  

Two new blocks were added in existing hospitals in FY 2023-24.

24. How many beds were added in FY 2023-24?  

A total of 280 beds were added in FY 2023-24, the highest ever in a single year.

25. Where did Rainbow Children’s Medicare achieve significant market penetration?  

Significant market penetration was achieved in Hyderabad, Bengaluru, and Chennai.

26. What is the hub-and-spoke model in Rainbow Children’s Medicare’s operations?      

The hub-and-spoke model involves central hospitals providing comprehensive care, while satellite facilities focus on emergency and outpatient services.

27. What areas does Rainbow Children’s Medicare plan to expand into?  

Rainbow Children’s Medicare plans to expand into Chennai, the National Capital Region, and tier-2 cities in Southern India.

28. What was the increase in other income due to?  

The increase in other income was primarily due to increased income from mutual funds and the reversal of expected credit losses.

29. What was the increase in total expenses for FY 2023-24?  

Total expenses rose by 12.63% in FY 2023-24.

30. How many hospitals received Joint Commission International (JCI) accreditation?  

Two hospitals received Joint Commission International (JCI) accreditation.

Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.